Mecamylamine ophthalmic - CoMentisAlternative Names: ATG 003; ATG-3
Latest Information Update: 15 Sep 2015
At a glance
- Originator CoMentis
- Class Eye disorder therapies; Norbornanes; Small molecules
- Mechanism of Action Nicotinic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Age-related macular degeneration; Diabetic macular oedema